 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Chimp Ban May Impact Research
UPI Senior Medical Correspondent Washington (UPI) May 25, 2007 Animal rights groups are celebrating the National Institutes of Health's recent decision to permanently end breeding of government-owned chimpanzees, but researchers say the move could be detrimental to biomedical and pharmaceutical research. The NIH's National Center for Research Resources, which has had a moratorium on breeding of federally supported chimpanzees since 1995, said this week the animals were of "continuing importance" to biomedical research, but that it could not afford to fund their upkeep. Chimps, which can live for more than 50 years in captivity, can cost as much as $500,000 in care over the span of an individual's life. Of the estimated 1,000 to 1,300 chimps in research facilities in the United States, NCRR supports approximately half. John Vandeberg, director of the Southwest National Primate Research Center in San Antonio, Texas, which houses chimpanzees sometimes used in experiments conducted by pharmaceutical companies, told United Press International the move would be detrimental to research into treatments for several diseases and conditions. "I'm disappointed by this announcement and it's disturbing to me," Vandeberg said. "I think it will have a devastating impact on some types of biomedical research, most importantly on hepatitis C and hepatitis B, other diseases for which chimps are used today, and other diseases that may emerge in the future." Vandeberg noted chimpanzees are the only animal model that can be infected with hepatitis C, making them crucial for testing potential vaccines and drugs against the virus. The animals also are extremely valuable for developing monoclonal antibodies, which have proven effective for treating rheumatoid arthritis and Crohn's disease, he said. Although animal rights groups have taken partial credit for affecting NCRR's decision, Vandeberg, who participated in the working group that helped guide the agency, thought the budget limitation was the real reason behind the move. "I do not believe that pressure from animal right activists had a bearing on the NCRR's decision," he said. The Humane Society of the United States and Project R and R: Release and Restitution for Chimpanzees in U.S. Laboratories, which led a campaign to pressure the NCRR to cease funding for breeding the primates, took partial credit for the government's decision and said the move would actually improve the quality of biomedical and pharmaceutical research. Theodora Capaldo, director of Project R and R, said the chimpanzee has not proven especially helpful as a model for insights into human disease or treatments. "When we stop using chimpanzees, there will not only not be a negative impact, there could be a positive impact, especially if we move towards research that we know gets us better results," Capaldo told UPI. This includes clinical and epidemiology studies and cell and tissue culture research, she said. "Chimpanzees are not used to any great extent in research in the three major killers: heart disease, cancer and AIDS," she said. Capaldo's group is currently developing three scientific papers to show chimpanzees are not necessary for biomedical research. "We can make the argument they're not helpful and even in those situations where they may be, they're not necessary," she said. Kathleen Conlee, director of program management for animal research issues for the Humane Society, told UPI the NCRR's decision to permanently cease funding of breeding of chimps will have a significant impact because it sends "a major message that this is not benefiting humans and it's costly." Conlee suggested the move would have a positive influence on biomedical research by freeing up resources for spending on other endeavors that she said may prove more fruitful and lead to better results. Her group plans to continue to campaign for retiring the remaining chimpanzees in research labs to sanctuaries. In 2002, NCRR awarded more than $30 million to the non-profit organization Chimp Haven to set up a sanctuary for federally owned or supported chimpanzees no longer needed for biomedical research, but the sanctuary is anticipated to reach full capacity in the next year. In addition to Southwest, chimpanzee research facilities in the United States include the Yerkes National Primate Research Center in Atlanta, the New Iberia Research Center in Louisiana and Bioqual in Rockville, Md. The Centers for Disease Control and Prevention and the Food and Drug Administration also house a small number of chimpanzees.
Source: United Press International Related Links NIH National Center for Research Resources Chimp Haven Hospital and Medical News at InternDaily.com
Urban Future Tries World Health
Washington (UPI) May 11, 2007Sometime in 2007, the majority of the world's population will live in cities for the first time in human history. Health systems are struggling to keep up. "Urban poverty and its implications on health transcend societies," said Diana Silimperi, a global maternal and child health expert. "I'm not sure that we as a civilization have even begun to come to grips with the ramifications of global urbanization," Silimperi said Thursday at the Woodrow Wilson International Center for Scholars in Washington. |
|
|
| The content herein, unless otherwise known to be public domain, are Copyright Space.TV Corporation. AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space.TV Corp on any Web page published or hosted by Space.TV Corp. Privacy Statement |
